ADCT
Price
$3.54
Change
+$0.14 (+4.12%)
Updated
Sep 5 closing price
Capitalization
398.25M
66 days until earnings call
CASI
Price
$2.34
Change
+$0.06 (+2.63%)
Updated
Sep 5 closing price
Capitalization
36.25M
Interact to see
Advertisement

ADCT vs CASI

Header iconADCT vs CASI Comparison
Open Charts ADCT vs CASIBanner chart's image
ADC Therapeutics SA
Price$3.54
Change+$0.14 (+4.12%)
Volume$1.16M
Capitalization398.25M
CASI Pharmaceuticals
Price$2.34
Change+$0.06 (+2.63%)
Volume$26.29K
Capitalization36.25M
ADCT vs CASI Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CASI commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and CASI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ADCT: $3.54 vs. CASI: $2.34)
Brand notoriety: ADCT and CASI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 179% vs. CASI: 2%
Market capitalization -- ADCT: $398.25M vs. CASI: $36.25M
ADCT [@Biotechnology] is valued at $398.25M. CASI’s [@Biotechnology] market capitalization is $36.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileCASI’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • CASI’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CASI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 6 TA indicator(s) are bullish while CASI’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 6 bullish, 3 bearish.
  • CASI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than CASI.

Price Growth

ADCT (@Biotechnology) experienced а +15.31% price change this week, while CASI (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($398M) has a higher market cap than CASI($36.3M). ADCT YTD gains are higher at: 77.889 vs. CASI (-17.314). CASI has higher annual earnings (EBITDA): -38.42M vs. ADCT (-115M). ADCT has more cash in the bank: 265M vs. CASI (12.7M). CASI has less debt than ADCT: CASI (18.5M) vs ADCT (118M). ADCT has higher revenues than CASI: ADCT (77.2M) vs CASI (31.4M).
ADCTCASIADCT / CASI
Capitalization398M36.3M1,096%
EBITDA-115M-38.42M299%
Gain YTD77.889-17.314-450%
P/E RatioN/AN/A-
Revenue77.2M31.4M246%
Total Cash265M12.7M2,087%
Total Debt118M18.5M638%
FUNDAMENTALS RATINGS
CASI: Fundamental Ratings
CASI
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCASI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CISO1.040.16
+18.20%
CISO Global
FOXF29.230.90
+3.18%
Fox Factory Holding Corp
CURI4.570.07
+1.56%
CuriosityStream
PANW194.462.11
+1.10%
Palo Alto Networks Inc
MTDR48.24-1.77
-3.54%
Matador Resources Company

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+4.12%
QTTB - ADCT
47%
Loosely correlated
+0.60%
VTYX - ADCT
44%
Loosely correlated
-3.08%
CLRB - ADCT
42%
Loosely correlated
N/A
RGNX - ADCT
40%
Loosely correlated
+3.08%
OCUL - ADCT
39%
Loosely correlated
+7.09%
More